Rubio Sends Letter to Pfizer CEO on Alleged Gain-of-Function ... - dofaq.co
Rubio Sends Letter to Pfizer CEO on Alleged Gain-of-Function ...
Pfizer Inc. (PFE): Among Billionaire Ken Fisher’s Healthcare Stock Picks with Massive Upside Potential
U.S. health officials inject new uncertainty into approval process for Covid boosters
1 Stock to Buy, 1 Stock to Sell This Week: Meta Platforms, Pfizer
Investing Action Plan: Apple, Amazon, Pfizer, Caterpillar And Sparring With The Fed
Pfizer: I Am Locking In 7.5% Dividend Yield Before Earnings (NYSE:PFE)
Pfizer’s Stock Outlook: Analysts Weigh In on Future Prospects
Will Pfizer's Non-COVID Drugs Drive Sales Again This Earnings Season?
Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer
Dividend Roundup: Pfizer, MetLife, Morgan Stanley, Kinder Morgan, and more
Pfizer Abandons Obesity Pill After Liver Injury in Setback
Nona Biosciences' Partner Pfizer Presents Preclinical Data on TOP1i-Based ADC Targeting MSLN at AACR Annual Meeting 2025
Is Pfizer Stock A Sell After Scrapping Another Obesity Drug?
How Will Pfizer Stock React To Its Upcoming Earnings?
Pfizer Declares Second-Quarter 2025 Dividend
Pfizer CEO Albert Bourla sees ‘a scientific renaissance’ in the U.S.
Pfizer announces $0.43 dividend for Q2 2025
Pfizer ends development of weight-loss pill danuglipron
Top Pfizer Shareholders
AUA25: Pfizer's sasanlimab-BCG combo shows 32% lower event risk in bladder cancer
